421
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Clinical toxicology and drug regulation: A United Kingdom perspective

&
Pages 452-456 | Received 25 Apr 2011, Accepted 31 May 2011, Published online: 04 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jennifer E. Shields, Paul I. Dargan, David M. Wood, Malgorzata Puchnarewicz, Susannah Davies & W. Stephen Waring. (2012) Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation. Clinical Toxicology 50:5, pages 438-440.
Read now
W Stephen Waring. (2012) Criteria for acetylcysteine treatment and clinical outcomes after paracetamol poisoning. Expert Review of Clinical Pharmacology 5:3, pages 311-318.
Read now

Articles from other publishers (10)

Christopher J. Weatherburn, Bruce Guthrie, Tobias Dreischulte & Daniel R. Morales. (2019) Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta‐analysis. British Journal of Clinical Pharmacology 86:4, pages 698-710.
Crossref
Priyanka Chandel, Ravindra K Rawal & Rupinder Kaur. (2018) Natural products and their derivatives as cyclooxygenase-2 inhibitors. Future Medicinal Chemistry 10:20, pages 2471-2492.
Crossref
Paul Acheampong, Gill Cooper, Behshad Khazaeli, David J. Lupton, Sue White, Margaret T. May & Simon H. L. Thomas. (2013) Effects of MHRA drug safety advice on time trends in prescribing volume and indices of clinical toxicity for quinine. British Journal of Clinical Pharmacology 76:6, pages 973-979.
Crossref
Andrew W. Hitchings, David M. Wood & Paul I. Dargan. (2013) Dissemination and uptake of a new treatment pathway for paracetamol poisoning in the UK: a survey of healthcare professionals. British Journal of Clinical Pharmacology 76:6, pages 946-950.
Crossref
Maximilian Gahr, Roland W. Freudenmann, Bernhard J. Connemann, Christoph Hiemke & Carlos Schönfeldt-Lecuona. (2013) Abuse liability of flupirtine revisited: Implications of spontaneous reports of adverse drug reactions. The Journal of Clinical Pharmacology 53:12, pages 1328-1333.
Crossref
Vijay Kulkarni, Swathi Swaroopa Bora, Sapineni Sirisha, Mohammed Saji & Siraj Sundaran. (2013) A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital. Therapeutic Advances in Drug Safety 4:4, pages 141-146.
Crossref
G. Thompson, S. B. Fatima, N. Shah, G. Kitching & W. S. Waring. (2013) Impact of Amending the Acetylcysteine Marketing Authorisation on Treatment of Paracetamol Overdose. ISRN Toxicology 2013, pages 1-5.
Crossref
M. J. Cooke & W. S. Waring. (2012) Citalopram and cardiac toxicity. European Journal of Clinical Pharmacology 69:4, pages 755-760.
Crossref
Hans C. Ebbers, Aukje K. Mantel-Teeuwisse, Fakhredin A. Sayed-Tabatabaei, Ellen H. M. Moors, Huub Schellekens & Hubert G. M. Leufkens. (2012) The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals. European Journal of Clinical Pharmacology 69:2, pages 217-226.
Crossref
Thomas M. Armstrong, Matthew S. Davies, Gary Kitching & W. Stephen Waring. (2012) Comparative Drug Dose and Drug Combinations in Patients that Present to Hospital Due to Self‐Poisoning. Basic & Clinical Pharmacology & Toxicology 111:5, pages 356-360.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.